Loading…
Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke
Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction,...
Saved in:
Published in: | The Journal of neuroscience 2014-11, Vol.34 (46), p.15200-15207 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3 |
---|---|
cites | cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3 |
container_end_page | 15207 |
container_issue | 46 |
container_start_page | 15200 |
container_title | The Journal of neuroscience |
container_volume | 34 |
creator | Shin, Hwa Kyoung Oka, Fumiaki Kim, Ji Hyun Atochin, Dmitriy Huang, Paul L Ayata, Cenk |
description | Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well. |
doi_str_mv | 10.1523/jneurosci.1110-14.2014 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4228129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1727696096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1ERUPhK1Q-ctnU47_rCxKKUlpU0Qro2fJ6vY3Lxg72Lmq-fR21VHDiNBq9N08z80PoFMgSBGVn99HPORUXlgBAGuBLSoC_Qouq6oZyAq_RglBFGskVP0ZvS7knhCgC6g06poJpylu9QDfr2Kdp48dgR9zvyzBHN4UUse1yurOTL7iq2A9DcNbtcRpwTHmbOpuDw5v9zuf0ECwOEZcpp5_-HToa7Fj8--d6gm7P1z9WF83V9efL1aerxglgUyP6vu96q4E5z4WSqgNmpSCt76SkApxqBfOdk6JlRFpJbee0YlR4VZuhZyfo41Pubu62vnc-TtmOZpfD1ua9STaYf5UYNuYu_Tac0haorgEfngNy-jX7MpltKM6Po40-zcWAokpqSbT8v7VuzJiuT61W-WR1lU7JfnjZCIg5kDNfvq5vv11_X12aAzkD3BzI1cHTv-95GfuDij0CYF2YYw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1625339539</pqid></control><display><type>article</type><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><source>NCBI_PubMed Central(免费)</source><creator>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</creator><creatorcontrib>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</creatorcontrib><description>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/jneurosci.1110-14.2014</identifier><identifier>PMID: 25392489</identifier><language>eng</language><publisher>United States: Society for Neuroscience</publisher><subject>Animals ; Apolipoproteins E - genetics ; Apolipoproteins E - physiology ; Cerebral Cortex - blood supply ; Cerebral Cortex - pathology ; Endothelium, Vascular - enzymology ; Endothelium, Vascular - physiopathology ; Hyperoxia ; Infarction, Middle Cerebral Artery - genetics ; Infarction, Middle Cerebral Artery - metabolism ; Infarction, Middle Cerebral Artery - pathology ; Infarction, Middle Cerebral Artery - therapy ; Male ; Mice ; Mice, Knockout ; Nitric Oxide Synthase Type III - genetics ; Nitric Oxide Synthase Type III - physiology</subject><ispartof>The Journal of neuroscience, 2014-11, Vol.34 (46), p.15200-15207</ispartof><rights>Copyright © 2014 the authors 0270-6474/14/3415200-08$15.00/0.</rights><rights>Copyright © 2014 the authors 0270-6474/14/3415200-08$15.00/0 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</citedby><cites>FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228129/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228129/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25392489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shin, Hwa Kyoung</creatorcontrib><creatorcontrib>Oka, Fumiaki</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Atochin, Dmitriy</creatorcontrib><creatorcontrib>Huang, Paul L</creatorcontrib><creatorcontrib>Ayata, Cenk</creatorcontrib><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</description><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - physiology</subject><subject>Cerebral Cortex - blood supply</subject><subject>Cerebral Cortex - pathology</subject><subject>Endothelium, Vascular - enzymology</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Hyperoxia</subject><subject>Infarction, Middle Cerebral Artery - genetics</subject><subject>Infarction, Middle Cerebral Artery - metabolism</subject><subject>Infarction, Middle Cerebral Artery - pathology</subject><subject>Infarction, Middle Cerebral Artery - therapy</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Nitric Oxide Synthase Type III - genetics</subject><subject>Nitric Oxide Synthase Type III - physiology</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vEzEQxS1ERUPhK1Q-ctnU47_rCxKKUlpU0Qro2fJ6vY3Lxg72Lmq-fR21VHDiNBq9N08z80PoFMgSBGVn99HPORUXlgBAGuBLSoC_Qouq6oZyAq_RglBFGskVP0ZvS7knhCgC6g06poJpylu9QDfr2Kdp48dgR9zvyzBHN4UUse1yurOTL7iq2A9DcNbtcRpwTHmbOpuDw5v9zuf0ECwOEZcpp5_-HToa7Fj8--d6gm7P1z9WF83V9efL1aerxglgUyP6vu96q4E5z4WSqgNmpSCt76SkApxqBfOdk6JlRFpJbee0YlR4VZuhZyfo41Pubu62vnc-TtmOZpfD1ua9STaYf5UYNuYu_Tac0haorgEfngNy-jX7MpltKM6Po40-zcWAokpqSbT8v7VuzJiuT61W-WR1lU7JfnjZCIg5kDNfvq5vv11_X12aAzkD3BzI1cHTv-95GfuDij0CYF2YYw</recordid><startdate>20141112</startdate><enddate>20141112</enddate><creator>Shin, Hwa Kyoung</creator><creator>Oka, Fumiaki</creator><creator>Kim, Ji Hyun</creator><creator>Atochin, Dmitriy</creator><creator>Huang, Paul L</creator><creator>Ayata, Cenk</creator><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20141112</creationdate><title>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</title><author>Shin, Hwa Kyoung ; Oka, Fumiaki ; Kim, Ji Hyun ; Atochin, Dmitriy ; Huang, Paul L ; Ayata, Cenk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - physiology</topic><topic>Cerebral Cortex - blood supply</topic><topic>Cerebral Cortex - pathology</topic><topic>Endothelium, Vascular - enzymology</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Hyperoxia</topic><topic>Infarction, Middle Cerebral Artery - genetics</topic><topic>Infarction, Middle Cerebral Artery - metabolism</topic><topic>Infarction, Middle Cerebral Artery - pathology</topic><topic>Infarction, Middle Cerebral Artery - therapy</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Nitric Oxide Synthase Type III - genetics</topic><topic>Nitric Oxide Synthase Type III - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shin, Hwa Kyoung</creatorcontrib><creatorcontrib>Oka, Fumiaki</creatorcontrib><creatorcontrib>Kim, Ji Hyun</creatorcontrib><creatorcontrib>Atochin, Dmitriy</creatorcontrib><creatorcontrib>Huang, Paul L</creatorcontrib><creatorcontrib>Ayata, Cenk</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shin, Hwa Kyoung</au><au>Oka, Fumiaki</au><au>Kim, Ji Hyun</au><au>Atochin, Dmitriy</au><au>Huang, Paul L</au><au>Ayata, Cenk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>2014-11-12</date><risdate>2014</risdate><volume>34</volume><issue>46</issue><spage>15200</spage><epage>15207</epage><pages>15200-15207</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>Hyperoxia has been uniformly efficacious in experimental focal cerebral ischemia. However, pilot clinical trials have showed mixed results slowing its translation in patient care. To explain the discordance between experimental and clinical outcomes, we tested the impact of endothelial dysfunction, exceedingly common in stroke patients but under-represented in experimental studies, on the neuroprotective efficacy of normobaric hyperoxia. We used hyperlipidemic apolipoprotein E knock-out and endothelial nitric oxide synthase knock-out mice as models of endothelial dysfunction, and examined the effects of normobaric hyperoxia on tissue perfusion and oxygenation using high-resolution combined laser speckle and multispectral reflectance imaging during distal middle cerebral artery occlusion. In normal wild-type mice, normobaric hyperoxia rapidly and significantly improved tissue perfusion and oxygenation, suppressed peri-infarct depolarizations, reduced infarct volumes, and improved neurological function. In contrast, normobaric hyperoxia worsened perfusion in ischemic brain and failed to reduce infarct volumes or improve neurological function in mice with endothelial dysfunction. These data suggest that the beneficial effects of hyperoxia on ischemic tissue oxygenation, perfusion, and outcome are critically dependent on endothelial nitric oxide synthase function. Therefore, vascular risk factors associated with endothelial dysfunction may predict normobaric hyperoxia nonresponders in ischemic stroke. These data may have implications for myocardial and systemic circulation as well.</abstract><cop>United States</cop><pub>Society for Neuroscience</pub><pmid>25392489</pmid><doi>10.1523/jneurosci.1110-14.2014</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-6474 |
ispartof | The Journal of neuroscience, 2014-11, Vol.34 (46), p.15200-15207 |
issn | 0270-6474 1529-2401 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4228129 |
source | NCBI_PubMed Central(免费) |
subjects | Animals Apolipoproteins E - genetics Apolipoproteins E - physiology Cerebral Cortex - blood supply Cerebral Cortex - pathology Endothelium, Vascular - enzymology Endothelium, Vascular - physiopathology Hyperoxia Infarction, Middle Cerebral Artery - genetics Infarction, Middle Cerebral Artery - metabolism Infarction, Middle Cerebral Artery - pathology Infarction, Middle Cerebral Artery - therapy Male Mice Mice, Knockout Nitric Oxide Synthase Type III - genetics Nitric Oxide Synthase Type III - physiology |
title | Endothelial dysfunction abrogates the efficacy of normobaric hyperoxia in stroke |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20dysfunction%20abrogates%20the%20efficacy%20of%20normobaric%20hyperoxia%20in%20stroke&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Shin,%20Hwa%20Kyoung&rft.date=2014-11-12&rft.volume=34&rft.issue=46&rft.spage=15200&rft.epage=15207&rft.pages=15200-15207&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/jneurosci.1110-14.2014&rft_dat=%3Cproquest_pubme%3E1727696096%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-5dddbda913ce45767b13a6508eb66251c7853ebc658306a62abc97325e7a62fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1625339539&rft_id=info:pmid/25392489&rfr_iscdi=true |